Clinical Report: Erratum: Presence of CTE-like tau filaments in Alzheimer’s disease
Background
Alzheimer’s disease (AD) is a leading cause of neurodegenerative pathology characterized by amyloid-β plaques and tau neurofibrillary tangles. Recent findings suggest that a significant number of individuals diagnosed with AD may also exhibit co-morbid conditions such as limbic-predominant age-related TDP-43 encephalopathy (LATE-NC), complicating diagnosis and treatment.
Data Highlights
No numerical or trial data is presented in the erratum.
Key Findings
The original article published in Acta Neuropathologica contained five supplementary tables that were incorrectly included in the main text.
The correction notice clarifies that these tables have been removed from the published version.
CTE-type tau filaments have been identified in cases of Alzheimer’s disease with co-morbid LATE-NC.
Recent literature emphasizes the importance of recognizing LATE-NC as a common co-pathology in late-life neurodegenerative diseases.
Diagnostic criteria for LATE have been proposed to standardize recognition when co-morbid with ADNC.
Clinical Implications
The correction of the article ensures that the scientific community has accurate information regarding the structural features of tau filaments in Alzheimer’s disease.
Conclusion
The erratum serves to clarify previously published information regarding tau filaments in Alzheimer’s disease.
